DROSTA P 150MG AQUILA PHARMACEUTICALS

Drostanolone Propionate 150 mg/mL (commonly referenced as Drosta P 150mg) is a high-purity, pharmaceutical-grade anabolic-androgenic steroid ester presented exclusively as an analytical reference material. This dihydrotestosterone (DHT)-derived compound is valued in laboratory settings for its rapid-acting propionate ester and exceptional stability in oil-based solutions. Regulated internationally as a controlled substance (Schedule III in the United States and equivalent classifications worldwide), it is intended solely for licensed research institutions, forensic laboratories, and accredited analytical facilities.

• Appearance: Clear, colorless to pale yellow viscous oil
• Concentration: 150 mg/mL (Drostanolone Propionate)
• Molecular Weight: 360.53 g/mol
• Chemical Formula: C23H36O3
• Solubility: Soluble in oils, ethanol, acetone; practically insoluble in water
• Structural Classification: 2α-methyl-dihydrotestosterone propionate ester

Drostanolone Propionate 150mg — Clinical & Pharmaceutical Reference Guide

Introduction

Drostanolone Propionate, frequently documented in scientific literature as Drosta P or Masteron Propionate, represents one of the most precisely characterized DHT-derived anabolic steroids in pharmaceutical research. The addition of the short propionate ester to the 2α-methylated dihydrotestosterone backbone creates a compound with rapid onset and predictable pharmacokinetic behavior in analytical models. Pharmaceutical-grade Drostanolone Propionate 150mg reference material is manufactured and verified under strict cGMP-compliant conditions to ensure researchers have access to material exceeding 99% purity. This guide provides detailed, medically accurate Drosta P 150mg information for educational and professional reference purposes only, with full adherence to global controlled-substance regulations.

Key Features & Scientific Relevance

• Pharmaceutical-grade purity routinely ≥99.5% (HPLC)
• Rapid ester clearance ideal for pharmacokinetic and metabolism studies
• Highly stable in grapeseed or MCT carrier oil formulations
• Essential reference standard for anti-doping laboratories and forensic toxicology
• Full compliance with DEA, EMA, WADA, and international controlled-substance protocols

The clinical profile of Drostanolone Propionate highlights its utility in validating LC-MS/MS methods, calibrating gas chromatography systems, and serving as a positive control in steroid screening panels.

Product Specifications

Drostanolone Propionate 150mg reference solutions are prepared under ISO-accredited conditions using pharmaceutical-grade active compound and sterile carrier oils.

• CAS Number: 521-12-0
• Synonyms: Dromostanolone Propionate, Masteril, Drosta P
• Molecular Formula: C23H36O3
• Exact Mass: 360.2664 Da
• Boiling Point: 432.5 ± 45 °C (predicted)
• Carrier Oil: Typically refined grapeseed oil or medium-chain triglycerides (MCT)
• Preservatives: Benzyl alcohol 2%, benzyl benzoate 15–20% (analytical-grade)
• Storage: 15–25 °C protected from light; remains stable >36 months when properly sealed

Applications & Usage

In strictly regulated laboratory environments, Drostanolone Propionate 150mg serves multiple analytical and research functions:

• Calibration and quality control in high-performance liquid chromatography (HPLC-DAD/UV)
• Matrix-matched standard in LC-MS/MS anti-doping and forensic assays
• Stability testing of oil-based parenteral reference formulations
• In vitro receptor-binding and metabolism studies using human liver microsomes
• Reference compound in steroid profiling for sports regulatory agencies

All applications remain confined to licensed, audited facilities operating under appropriate controlled-substance permits.

Purity & Analytical Testing

Every batch undergoes comprehensive third-party analysis using validated methodologies:

• HPLC-UV: ≥99.5% purity with full impurity profiling
• GC-MS: Confirmation of molecular ion m/z 360 and characteristic fragments
• 1H-NMR & 13C-NMR: Complete structural verification against USP reference standard
• FTIR: Carbonyl stretch at ~1735 cm⁻¹ confirming propionate ester
• Karl Fischer: Residual moisture <0.1%
• Heavy metals & residual solvents: Below ICH Q3D and Q3C limits

Certificates of Analysis (CoA) are archived and available to authorized institutions upon request.

Safety & Handling Guidelines

As a Schedule III / List I chemical, Drostanolone Propionate requires:

• Class II biological safety cabinet or certified fume hood for handling
• Nitrile or latex gloves, laboratory coat, and eye protection
• Secure, double-locked storage with access logging
• Temperature monitoring (15–25 °C); avoid freezing
• Spill response: absorbent pads and solvent-compatible neutralization
• Waste disposal via licensed hazardous-waste contractor

Secure & Confidential Distribution for Institutions

Delivery to qualified entities occurs through vetted, compliance-focused logistics partners:

• Unmarked, tamper-evident exterior packaging
• Amber pharmaceutical vials with PTFE/silicone septa
• Temperature-controlled shipping with data loggers
• Electronic CoA transmitted via encrypted portal
• Recipient verification against current DEA/EMA license database

Why Choose This Reference Material?

• Verified ≥99.5% purity backed by full analytical suite
• Exact 150 mg/mL concentration for direct use in calibration curves
• Comprehensive spectral data library included
• Trusted by WADA-accredited, Olympic, and university research laboratories worldwide
• Full regulatory traceability and documentation support

Legal & Safety Disclaimer

Drostanolone Propionate 150mg reference material is supplied exclusively for analytical, research, and educational purposes within licensed institutions. It is strictly prohibited for human or veterinary administration, private possession, or any non-laboratory use. All acquisition, storage, handling, and disposal must comply with applicable national and international controlled-substance laws. Possession without proper authorization may constitute a serious criminal offense.

FAQ Section

What is the clinical classification of Drostanolone Propionate? Drostanolone Propionate is classified as a synthetic anabolic-androgenic steroid derived from dihydrotestosterone with a 2α-methyl substitution.

Is Drosta P 150mg a regulated substance? Yes. It is listed as Schedule III (USA), Class C (UK), and appears on WADA Prohibited List S1 (anabolic agents) worldwide.

How is pharmaceutical-grade purity verified? Through a combination of HPLC-UV, GC-MS, NMR, and FTIR performed by ISO/IEC 17025-accredited laboratories.

How should Drosta P 150mg reference solutions be stored? At controlled room temperature (15–25 °C) in a secure, locked cabinet, protected from light and unauthorized access.

Who is authorized to possess Drostanolone Propionate reference material? Only institutions holding valid DEA research registration, EMA authorization, or equivalent controlled-substance licenses.

Can Drosta P 150mg be used for human administration? No. This material is strictly prohibited from any medical, therapeutic, or performance-enhancing use in humans or animals.